Name: <meta charset="utf8"></head><body>Författare Spotlight: Undersöker cellulär och molekylär dynamik under muskelregenerering med hjälp av banbrytande encellsteknologier
Uploaded: 2023-12-01T14:35:00
Description: Read this Scientific Article Protocol about Author Spotlight: Investigating Cellular and Molecular Dynamics during Muscle Regeneration Using Cutting-Edge Single-Cell Technologies at JoVE.com

<meta charset="utf8"></head><body>Encellsbaserad CyTOF-analys av myogena stamceller vid muskelregenerering

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>15 mL centrifuge tube</td>
			<td>Fisher Scientific</td>
			<td>07-200-886</td>
			<td></td>
		</tr>
		<tr>
			<td>20 G needle</td>
			<td>KDM</td>
			<td>KD-fine 900123</td>
			<td></td>
		</tr>
		<tr>
			<td>28 G, 0.5 mL insulin syringe&#160;</td>
			<td>BD</td>
			<td>329461</td>
			<td></td>
		</tr>
		<tr>
			<td>29 G, 0.3 mL insulin syringe</td>
			<td>BD</td>
			<td>324702</td>
			<td></td>
		</tr>
		<tr>
			<td>3 mL syringes</td>
			<td>Terumo medical</td>
			<td>MDSS03SE</td>
			<td></td>
		</tr>
		<tr>
			<td>40 &#181;m cell strainers</td>
			<td>Fisher Scientific</td>
			<td>11587522</td>
			<td></td>
		</tr>
		<tr>
			<td>5 mL polypropylene tubes&#160;</td>
			<td>Fisher Scientific</td>
			<td>352002</td>
			<td></td>
		</tr>
		<tr>
			<td>5 mL polystyrene test tubes with 35 &#181;m cell strainer</td>
			<td>Falcon</td>
			<td>352235</td>
			<td></td>
		</tr>
		<tr>
			<td>5 mL syringes</td>
			<td>Terumo medical</td>
			<td>SS05LE1</td>
			<td></td>
		</tr>
		<tr>
			<td>50 mL centrifuge tube</td>
			<td>Fisher Scientific</td>
			<td>05-539-13</td>
			<td></td>
		</tr>
		<tr>
			<td>5-Iodo-2-deoxyuridine (IdU)</td>
			<td>Merck</td>
			<td>I7125-5g</td>
			<td></td>
		</tr>
		<tr>
			<td>anti-CD104 FITC (clone: 346-11A)</td>
			<td>Biolegend</td>
			<td>123605</td>
			<td>Stock = 0.5 mg/mL</td>
		</tr>
		<tr>
			<td>anti-CD11b APC-Cy7 (Clone: M1/70)</td>
			<td>Biolegend</td>
			<td>101226</td>
			<td>Stock = 0.2 mg/mL</td>
		</tr>
		<tr>
			<td>anti-CD31 APC-Cy7 (clone: 390)</td>
			<td>Biolegend</td>
			<td>102440</td>
			<td>Stock = 0.2 mg/mL</td>
		</tr>
		<tr>
			<td>anti-CD45 APC-Cy7 (Clone: 30-F11)</td>
			<td>Biolegend</td>
			<td>103116</td>
			<td>Stock = 0.2 mg/mL</td>
		</tr>
		<tr>
			<td>anti-CD9 APC (clone: KMC8)</td>
			<td>ThermoFisher Scientific</td>
			<td>17-0091-82</td>
			<td>Stock = 0.2 mg/mL</td>
		</tr>
		<tr>
			<td>anti-Sca1 (Ly6A/E) APC-Cy7 (clone: D7)</td>
			<td>Biolegend</td>
			<td>108126</td>
			<td>Stock = 0.2 mg/mL</td>
		</tr>
		<tr>
			<td>anti-&#945;7 integrin PE (clone: R2F2))</td>
			<td>UBC AbLab</td>
			<td>67-0010-05</td>
			<td>Stock = 1 mg/mL</td>
		</tr>
		<tr>
			<td>BD FACS Aria III (4 laser) instrument</td>
			<td>BD Biosciences</td>
			<td>N/A</td>
			<td>405, 488, 561, and 633 nm laser</td>
		</tr>
		<tr>
			<td>Bovine Serum Albumin</td>
			<td>Sigma Aldrich</td>
			<td>A7030-50G</td>
			<td></td>
		</tr>
		<tr>
			<td>Buprenorphine 0.3 mg/mL</td>
			<td>Ceva</td>
			<td>Vnr 054594</td>
			<td></td>
		</tr>
		<tr>
			<td>CD104 (Clone: 346-11A)</td>
			<td>BD Biosciences</td>
			<td>553745</td>
			<td>Dy162; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD106/VCAM-1 (Clone: 429 MVCAM.A)</td>
			<td>Biolegend</td>
			<td>105701</td>
			<td>Er170; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD11b (Clone: M1/70)</td>
			<td>BD Biosciences</td>
			<td>553308</td>
			<td>Nd148; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD29/Integrin &#946;1 (Clone: 9EG7)</td>
			<td>BD Biosciences</td>
			<td>553715</td>
			<td>Tm169; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD31 (Clone: MEC 13.3)</td>
			<td>BD Biosciences</td>
			<td>557355</td>
			<td>Sm154; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD34 (Clone: RAM34)</td>
			<td>BD Biosciences</td>
			<td>551387</td>
			<td>Lu175; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD44 (Clone: IM7)</td>
			<td>BD Biosciences</td>
			<td>550538</td>
			<td>Yb171; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD45 (Clone: MEC 30-F11)</td>
			<td>BD Biosciences</td>
			<td>550539</td>
			<td>Sm147; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD9 (Clone: KMC8)</td>
			<td>Thermo Fisher Scientific</td>
			<td>14-0091-85</td>
			<td>Yb174; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD90.2/Thy1.2 (Clone: 30-H12)</td>
			<td>BD Biosciences</td>
			<td>553009</td>
			<td>Nd144; In-house conjugated</td>
		</tr>
		<tr>
			<td>CD98 (Clone: H202-141)</td>
			<td>BD Biosciences</td>
			<td>557479</td>
			<td>Pr141; In-house conjugated</td>
		</tr>
		<tr>
			<td>Cell Acquisition Solution/Maxpar CAS-buffer</td>
			<td>Standard Biotools</td>
			<td>201240</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell-ID Intercalator-Iridium</td>
			<td>Standard Biotools</td>
			<td>201192B</td>
			<td>cationic nucleic acid intercalator</td>
		</tr>
		<tr>
			<td>Cisplatin</td>
			<td>Merck</td>
			<td>P4394</td>
			<td>Pt195</td>
		</tr>
		<tr>
			<td>Cisplatin (cis-Diammineplatinum(II) dichloride)</td>
			<td>Merck</td>
			<td>P4394</td>
			<td></td>
		</tr>
		<tr>
			<td>Clear 1.5 mL tube</td>
			<td>Fisher Scientific</td>
			<td>11926955</td>
			<td></td>
		</tr>
		<tr>
			<td>Collagenase, Type II</td>
			<td>Worthington Biochemical Corporation</td>
			<td>LS004177</td>
			<td></td>
		</tr>
		<tr>
			<td>Counting chamber</td>
			<td>Merck</td>
			<td>BR718620-1EA</td>
			<td></td>
		</tr>
		<tr>
			<td>CXCR4/SDF1 (Clone: 2B11/CXCR4 )</td>
			<td>BD Biosciences</td>
			<td>551852</td>
			<td>Gd158; In-house conjugated</td>
		</tr>
		<tr>
			<td>DAPI (1 mg/mL)</td>
			<td>BD Biosciences</td>
			<td>564907</td>
			<td></td>
		</tr>
		<tr>
			<td>Dark 1.5 mL tube</td>
			<td>Fisher Scientific</td>
			<td>15386548</td>
			<td></td>
		</tr>
		<tr>
			<td>Dispase II</td>
			<td>Thermo Fisher Scientific</td>
			<td>17105041</td>
			<td></td>
		</tr>
		<tr>
			<td>Dissection Scissors</td>
			<td>Fine Science Tools</td>
			<td>14568-09</td>
			<td></td>
		</tr>
		<tr>
			<td>DMEM (low glucose, with pyruvate)</td>
			<td>Thermo Fisher Scientific</td>
			<td>11885-092</td>
			<td></td>
		</tr>
		<tr>
			<td>EDTA (Ethylenediaminetetraacetic acid disodium salt)</td>
			<td>Merck</td>
			<td>E5134</td>
			<td>Na2EDTA-2H20</td>
		</tr>
		<tr>
			<td>EQ Four Element Calibration Beads (EQ beads)</td>
			<td>Standard Biotools</td>
			<td>201078</td>
			<td>Calibration beads</td>
		</tr>
		<tr>
			<td>Fetal Bovine Serum, qualified, Brazil origin</td>
			<td>Thermo Fisher Scientific</td>
			<td>10270106</td>
			<td></td>
		</tr>
		<tr>
			<td>Forceps Dumont #5SF</td>
			<td>Fine Science Tools</td>
			<td>11252-00</td>
			<td></td>
		</tr>
		<tr>
			<td>Forceps Dumont #7</td>
			<td>Hounisen.com</td>
			<td>1606.3350</td>
			<td></td>
		</tr>
		<tr>
			<td>Goat serum</td>
			<td>Thermo Fisher Scientific</td>
			<td>16210-072</td>
			<td></td>
		</tr>
		<tr>
			<td>Helios CyTOF system</td>
			<td>Standard Biotools</td>
			<td>N/A</td>
			<td></td>
		</tr>
		<tr>
			<td>Horse Serum, heat inactivated, New Zealand origin</td>
			<td>Thermo Fisher Scientific</td>
			<td>26-050-088</td>
			<td></td>
		</tr>
		<tr>
			<td>IdU</td>
			<td>Merck</td>
			<td>I7125</td>
			<td>I127</td>
		</tr>
		<tr>
			<td>Iridium-Intercalator</td>
			<td>Standard Biotools</td>
			<td>201240</td>
			<td>Ir191/193</td>
		</tr>
		<tr>
			<td>Isoflurane/Attane Vet</td>
			<td>ScanVet</td>
			<td>Vnr 055226</td>
			<td></td>
		</tr>
		<tr>
			<td>Methanol</td>
			<td>Fisher Scientific</td>
			<td>M/3900/17</td>
			<td></td>
		</tr>
		<tr>
			<td>Myf5 (Clone: C-20)</td>
			<td>Santa Cruz Biotechnology</td>
			<td>Sc-302</td>
			<td>Yb173; In-house conjugated</td>
		</tr>
		<tr>
			<td>MyoD (Clone: 5.8A)</td>
			<td>BD Biosciences</td>
			<td>554130</td>
			<td>Dy164; In-house conjugated</td>
		</tr>
		<tr>
			<td>MyoG (Clone: F5D)</td>
			<td>BD Biosciences</td>
			<td>556358</td>
			<td>Gd160; In-house conjugated</td>
		</tr>
		<tr>
			<td>Nalgene Rapid-Flow Sterile Disposable Bottle Top 0.20 &#956;M PES Filters</td>
			<td>Thermo Fisher Scientific</td>
			<td>595-4520</td>
			<td></td>
		</tr>
		<tr>
			<td>Notexin</td>
			<td>Latoxan</td>
			<td>L8104</td>
			<td>Resuspend to 50 &#181;g/ml in sterile PBS. Keep stocks (e.g. 50 &#181;l) at -20 &#176;C</td>
		</tr>
		<tr>
			<td>Nutrient mixture F-10 (Ham&#39;s)</td>
			<td>Thermo Fisher Scientific</td>
			<td>31550031</td>
			<td></td>
		</tr>
		<tr>
			<td>pAkt (Clone: D9E)</td>
			<td>Standard Biotools</td>
			<td>3152005A</td>
			<td>Sm152</td>
		</tr>
		<tr>
			<td>Pax7 (Clone: PAX7)</td>
			<td>Santa Cruz Biotechnology</td>
			<td>Sc-81648</td>
			<td>Eu153; In-house conjugated</td>
		</tr>
		<tr>
			<td>Penicillin-Streptomycin (10,000 U/mL) (Pen/Strep)</td>
			<td>Thermo Fisher Scientific</td>
			<td>15140122</td>
			<td></td>
		</tr>
		<tr>
			<td>PES Filter Units 0.20 &#956;M</td>
			<td>Fisher Scientific</td>
			<td>15913307</td>
			<td></td>
		</tr>
		<tr>
			<td>PES Syringe Filter</td>
			<td>Fisher Scientific</td>
			<td>15206869</td>
			<td></td>
		</tr>
		<tr>
			<td>Petri dish</td>
			<td>Sarstedt</td>
			<td>82.1472.001</td>
			<td></td>
		</tr>
		<tr>
			<td>PFA 16% EM grade</td>
			<td>MP Biomedicals</td>
			<td>219998320</td>
			<td></td>
		</tr>
		<tr>
			<td>Potassium chloride (KCl)</td>
			<td>Fisher Scientific</td>
			<td>10375810</td>
			<td></td>
		</tr>
		<tr>
			<td>Potassium phosphate, monobasic,&#160;anhydrous (KH2PO4)</td>
			<td>Fisher Scientific</td>
			<td>10573181</td>
			<td></td>
		</tr>
		<tr>
			<td>pRb (Clone: J112-906)</td>
			<td>Standard Biotools</td>
			<td>3166011A</td>
			<td>Er166</td>
		</tr>
		<tr>
			<td>pS6 kinase (Clone: N7-548)</td>
			<td>Standard Biotools</td>
			<td>3172008A</td>
			<td>Yb172</td>
		</tr>
		<tr>
			<td>Sca-1 (Clone: E13-161.7)</td>
			<td>BD Biosciences</td>
			<td>553333</td>
			<td>Nd142; In-house conjugated</td>
		</tr>
		<tr>
			<td>Sodium Azide</td>
			<td>Sigma Aldrich</td>
			<td>S2002</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium chloride (NaCl)</td>
			<td>Fisher Scientific</td>
			<td>10553515</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium phosphate, dibasic, heptahydrate (Na2HPO4-6H2O)</td>
			<td>Merck</td>
			<td>S9390</td>
			<td></td>
		</tr>
		<tr>
			<td>Sterile saline solution 0.9%</td>
			<td>Fresenius</td>
			<td>B306414/02</td>
			<td></td>
		</tr>
		<tr>
			<td>&#945;7 integrin (Clone: 3C12)</td>
			<td>MBL international</td>
			<td>K0046-3</td>
			<td>Ho165; In-house conjugated</td>
		</tr>
	</tbody>
</table>

identification and analysis of myogenic progenitors in vivo during acute skeletal muscle injury by high-dimensional single-cell mass cytometry

Skeletal muscle constitutes the largest tissue by mass in the body and regulates multiple functions, from eyesight to respiration, from posture to movement, as well as metabolism1. Therefore, maintaining skeletal muscle integrity and function is critical to health. Skeletal muscle tissue, which consists of tightly packed bundles of multinucleated myofibers surrounded by a complex network of nerves and blood vessels, exhibits remarkable regenerative potential1,2.
The main drivers of skeletal muscle regeneration are adult muscle stem cells (MuSCs). Also known as satellite cells, due to their unique anatomical location adjacent to the plasma membrane of the myofiber and beneath the basal lamina, they were first identified in 19613. MuSCs express a unique molecular marker, the transcription factor paired box 7 (Pax7)4. Mostly quiescent in healthy adults, they become activated upon muscle injury and proliferate to give rise to progeny that will (i) differentiate into fusion-competent muscle cells that will form new myofibers to repair muscle damage or (ii) self-renew to replenish the stem cell pool5.
At the cellular and molecular level, the process of regeneration is quite dynamic and involves cell-state transitions, characterized by the coordinated expression of key myogenic transcription factors, also known as myogenic regulatory factors (MRFs)6,7. Prior in vivo developmental studies, lineage tracing experiments, and cell culture work using myoblasts&#160;have shown that sequential expression of these transcription factors drives myogenesis, with myogenic factor 5 (Myf5) being expressed upon activation, myogenic differentiation 1 (MyoD1) expression marking commitment to the myogenic program, and myogenin (MyoG) expression marking differentiation8,9,10,11,12,13,14. Despite this knowledge and the discovery of cell surface markers to purify MuSCs, strategies and tools to identify and isolate discrete populations along the myogenic differentiation path and resolve a myogenic progression in vivo have been lacking15,16,17,18.
Here, we present a novel method, based on recently published research, which enables the identification of stem and progenitor cells in skeletal muscle and the analysis of their cellular, molecular, and proliferation dynamics in the context of acute muscle injury19. This approach relies on single-cell mass cytometry (also known as Cytometry by Time of Flight [CyTOF]) to simultaneously detect key cell surface markers (&#945;7&#160;integrin, CD9, CD44, CD98, and CD104), intracellular myogenic transcription factors (Pax7, Myf5, MyoD, and MyoG) and a nucleoside analog (5-Iodo-2&#8242;-deoxyuridine, IdU), to monitor cells in S phase19,20,21,22,23. Moreover, the protocol presents a strategy based on the detection of two cell surface markers, CD9 and CD104, to purify these cell populations by fluorescence-activated cell sorting (FACS), therefore enabling future in-depth studies of their function in the context of injury and muscle diseases. While primary myoblasts have been extensively used in the past to study the late stages of myogenic differentiation in vitro, it is not known whether they recapitulate the molecular state of muscle progenitor cells found in vivo24,25,26,27,28,29,30. The production of myoblasts is laborious and time-consuming, and the molecular state of this primary culture changes rapidly upon passaging31. Hence, freshly isolated myogenic progenitors purified with this method will provide a more physiological system to study myogenesis and the effect of genetic or pharmacological manipulations ex-vivo.
The protocol presented here can be applied to address a variety of research questions, for example, to study the dynamics of the myogenic compartment in vivo in animal models of muscle diseases, in response to acute genetic manipulations or upon pharmacological interventions, therefore deepening our understanding of muscle stem cell dysfunction in different biological contexts and facilitating the development of novel therapeutic interventions.

<meta charset="utf8"></head><body>Författare Spotlight: Undersöker cellulär och molekylär dynamik under muskelregenerering med hjälp av banbrytande encellsteknologier

Identifiering och analys av myogena stamceller in vivo under akut skelettmuskelskada genom högdimensionell encellig masscytometri

Our research investigates the molecular mechanisms underlying stem cell dysfunction in aging and disease. Our goal is to understand how muscle stem and progenitor cells interact with other cells in the muscle microenvironment to achieve effective regeneration. We are also studying whether a barren cell communication impacts muscle stem cell function in aging and disease.A major barrier to investigating cell-cell communication within the stem cell niche has been the lack of technologies that provide single cell resolution. Single cell mass cytometry allows simultaneous high throughput quantitative analysis on multiple cell types and molecular phenotypes in complex tissues. Our protocol enables purification and deep profiling of rare stem cells and the progeny during muscle regeneration using antibodies to cell surface markers and myogenic transcription factors.Studying these cells helps us understand how muscle stem cell fates is controlled, and uncover the networks that drive cell state transitions doing effective regeneration. Measuring up to 50 cell surface and intracellular protein simultaneously at a single cell level is a valuable approach for investigating cellular function in muscle tissue. This technique can identify unique molecular signatures and reveal novel mechanisms of muscle stem cell dysfunction in aging and disease.This protocol allows to investigate how cell state transition impact tissue regeneration in health and disease. The signature of activated stem cells we present here enable studies of stem cell quiescence. They were not previously possible.We can now purify activated stem cells, CD98 High, CD44 High, based solely on cell surface marker, and study for the first time, how they return to quiescence.

Read this Scientific Article Protocol about Author Spotlight: Investigating Cellular and Molecular Dynamics during Muscle Regeneration Using Cutting-Edge Single-Cell Technologies at JoVE.com

Skeletal muscle regeneration is a dynamic process driven by adult muscle stem cells and their progeny. Mostly quiescent at a steady state, adult muscle ...

identification-analysis-myogenic-progenitors-vivo-during-acute

Research

JoVE Journal

Biology

Identification and Analysis of Myogenic Progenitors In Vivo During Acute Skeletal Muscle Injury by High-Dimensional Single-Cell Mass Cytometry

Skeletal muscle regeneration is a dynamic process driven by adult muscle stem cells and their progeny. Mostly quiescent at a steady state, adult muscle stem cells become activated upon muscle injury. Following activation, they proliferate, and most of their progeny differentiate to generate fusion-competent muscle cells while the remaining self-renews to replenish the stem cell pool. While the identity of muscle stem cells was defined more than a decade ago, based on the co-expression of cell surface markers, myogenic progenitors were identified only recently using high-dimensional single-cell approaches. Here, we present a single-cell mass cytometry (cytometry by time of flight [CyTOF]) method to analyze stem cells and progenitor cells in acute muscle injury to resolve the cellular and molecular dynamics that unfold during muscle regeneration. This approach is based on the simultaneous detection of novel cell surface markers and key myogenic transcription factors whose dynamic expression enables the identification of activated stem cells and progenitor cell populations that represent landmarks of myogenesis. Importantly, a sorting strategy based on detecting cell surface markers CD9 and CD104 is described, enabling prospective isolation of muscle stem and progenitor cells using fluorescence-activated cell sorting (FACS) for in-depth studies of their function. Muscle progenitor cells provide a critical missing link to study the control of muscle stem cell fate, identify novel therapeutic targets for muscle diseases, and develop cell therapy applications for regenerative medicine. The approach presented here can be applied to study muscle stem and progenitor cells in vivo in response to perturbations, such as pharmacological interventions targeting specific signaling pathways. It can also be used to investigate the dynamics of muscle stem and progenitor cells in animal models of muscle diseases, advancing our understanding of stem cell diseases and accelerating the development of therapies.

The protocol presented here enables the identification and high-dimensional analysis of muscle stem and progenitor cells by single-cell mass cytometry and their purification by FACS for in-depth studies of their function. This approach can be applied to study regeneration dynamics in disease models and test the efficacy of pharmacological interventions.

Induction of Acute Injury by Notexin Injection in the Mouse Skeletal Muscle

To begin, place the vials of buprenorphine diluted in sterile, 0.9%saline, and notexin, diluted in PBS, on ice. Under the nose cone setup, shave the hind limbs of an anesthetized mouse with a trimmer, then transfer the mouse back into the induction box. Prepare insulin syringes with 15 microliters of notexin solution for GA, and 10 microliters of notexin solution for TA injections.Once the mouse is moved to the nose cone set up, disinfect the injection site with an ethanol wipe. Insert the needle with the bevel facing downwards in the belly of the TA muscle at a 30 degree angle. Advance the needle parallel to the tibia to reach the mid-belly of the TA and inject the notexin solution slowly for 10 seconds.To inject the notexin solution into the GA, insert the needle at a 45 degree angle in the mid-belly of the lateral head of the GA muscle and inject the solution. Turn the mouse around and, using an insulin syringe, inject buprenorphine subcutaneously. Calculate the volume of the iododeoxyuridine solution required for each mouse using this equation.Using an insulin syringe, perform an intraperitoneal injection of iododeoxyuridine solution at the sterilized injection site 8 to 12 hours before euthanasia.

Induktion av akut skada genom Notexin-injektion i musens skelettmuskel

Dissection of the Mouse Skeletal Muscle After Notexin Injury and Cell Dissociation Procedure for Single-Cell Analysis

After euthanizing the mouse, dissect TA and GA muscles from both hind limbs and place them in the lid of a Petri dish. Use scissors to cut the tissue into a minced slurry. Transfer the minced tissue to a 50-milliliter tube containing five milliliters of ice cold dissociation buffer, and keep it on ice.Once the sample tubes are heated at 37 degrees Celsius, incubate them for 45 minutes on rotation in an incubator. Add 10 milliliters of wash media to the sample tubes and vortex them. Centrifuge the tubes, and aspirate the contents to four milliliters.Next, add 0.5 milliliters each of collagenase and dispase to the cells. Then, vortex and incubate them. After incubation, centrifuge the digested sample and resuspend the pellet with a five-milliliter pipette.Next, pre-wet the 40-micrometer cell strainers placed on 50-milliliter tubes with five milliliters of wash media. Using a five-milliliter syringe with a 20-gauge needle, aspirate and eject the cell suspension 10 times. Then, strain the cell suspension through the pre-wetted 40-micrometer cell strainer.After collecting and straining the remaining cells with 10 milliliters of wash media, pellet the cell suspension by centrifugation, aspirate the supernatant from the tube, and gently flick the pellet to loosen it.

Dissektion av musens skelettmuskel efter Notexin-skada och celldissociationsprocedur för encellsanalys

Live/Dead Staining of Skeletal Muscle Cells, Isolated from Notexin-Injured Mice, with Cisplatin and Paraformaldehyde Fixation

To begin, resuspend the skeletal muscle cells isolated from Notexin-injured mice labeled with iododeoxyuridine in one milliliter of cold serum free DMEM and count them using a hemocytometer or a cell counter. Under a fume hood, add cisplatin stock to achieve a final concentration of 25 micromolar. Vortex the tube for 10 seconds and incubate at room temperature for one minute.Quench the reaction with ice cold DMEM containing 10%FBS and place it on ice. After pelleting and resuspending the cells, filter the suspension through a 35 micrometer cell strainer. Under a fume hood, add filtered paraformaldehyde stock solution to fix the cell suspension and vortex for 30 seconds.Wash it two times with two milliliters of cell staining medium or CSM by centrifugation. After the final wash, aspirate the supernatant to approximately 60 microliters and thoroughly resuspend the pellet. Add 40 microliters of 2.5 times surface antibody staining mix prepared in CSM and incubate for one hour while vortexing them every 20 minutes.After washing the sample two times with CSM, aspirate the supernatant and flick the pellet. To permeabilize the cells, under a fume hood, add 0.5 milliliters of ice cold methanol dropwise while vortexing. Wash the cells twice with one milliliter of CSM by centrifugation.After the last wash, aspirate the supernatant to approximately 60 microliters and resuspend the pellet thoroughly. Incubate the cells with 40 microliters of intracellular antibody staining mix for one hour, while vortexing the samples every 20 minutes. After washing the cells twice with one milliliter CSM, resuspend the samples in 0.5 milliliters of the intercalator iridium solution and vortex.

Levande/död färgning av skelettmuskelceller, isolerade från Notexin-skadade möss, med bindning av cisplatin och paraformaldehyd

Skeletal Muscle Cells Preparation for Loading into Mass Cytometer and CyTOF Data Analysis

To begin, take the skeletal muscle cells stained with cisplatin, metal conjugated antibodies, and intercalator-iridium solution, and pellet the cells by centrifugation. Once the supernatant is removed, add one milliliter of CSM to the vortexed cells. Pellet the cells by centrifugation and wash in one milliliter of CAS buffer.After centrifugation, aspirate the supernatant to approximately 200 microliters. Add one milliliter of CAS buffer to the vortexed samples and aliquot five microliters for cell count. After centrifuging the cells and aspirating the supernatant to 50 microliters, resuspend the cells in CAS buffer to a final concentration of 1 million cells per milliliter and add calibration beads to achieve a final concentration of 0.1x.Load the sample into the mass cytometer to collect data using a flow rate of 400 to 500 cells per second, and normalize the data after collection. If necessary, concatenate individual Flow Cytometry Standard or FCS files for each sample into a single file. Identify single cells by gating on iridium intercalator positive events.Select events that are negative for cisplatin to gate for live cells. Gate on the population of interest and quantify the relative proportion of stem and progenitor cells. To perform high-dimensional analysis, export the population of interest and use clustering algorithms.For X-shift analysis, download the Vortex software package and Java 64-bit. Upload the exported cell populations to a local database and define the clustering parameters. To visualize the spatial relationships between cell populations within the X-shift clusters, perform a force-directed layout.CyTOF analysis identified a sequence of four populations, stem cells, and progenitor populations one through three. The progenitor populations P1 and P2 correspond to increasingly more mature progenitor cells. P3 was previously identified but not characterized due to its low abundance.The stem and progenitor cell dynamics post-injury were analyzed using CD9 by CD104 by axial dot plots. A notable increase in the stem cell population was observed on day three, suggesting expansion. This was supported by increased iododeoxyuridine incorporation, indicating cell proliferation, and heightened MyoD expression as shown by the color overlay.Activated stem cells marked by high levels of CD98, CD44, MyoD, and iododeoxyuridine were identified, underscoring their high proliferation and activated state at day three post-injury.